AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 15 filers reported holding AYALA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $862 | -100.0% | 2,153,273 | 0.0% | 0.02% | -64.2% |
| Q3 2022 | $2,153,000 | -8.3% | 2,153,273 | 0.0% | 0.05% | +8.2% |
| Q2 2022 | $2,347,000 | -72.6% | 2,153,273 | -0.0% | 0.05% | -65.0% |
| Q1 2022 | $8,572,000 | -53.2% | 2,153,860 | +0.0% | 0.14% | -59.5% |
| Q4 2021 | $18,328,000 | +305366.7% | 2,153,648 | +406248.7% | 0.35% | – |
| Q3 2021 | $6,000 | +20.0% | 530 | +15.7% | 0.00% | – |
| Q2 2021 | $5,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 542,977 | $5,533,000 | 1.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,364 | $238,000 | 0.11% |
| Redmile Group, LLC | 667,816 | $6,805,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,962 | $326,000 | 0.01% |
| Marshall Wace North America L.P. | 49,266 | $502,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 704,363 | $7,178,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $153,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 470 | $4,000 | 0.00% |
| UBS Group AG | 5,509 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |